After more than 10 years of research, Monsanto scientists have developed improved seed potatoes that are protected from serious pests, including insects and disease. The first commercial products resulting from this effort were NewLeaf ® potatoes derived from `Russet Burbank' and `Atlantic' parents. The NewLeaf® product was commercialized in 1995 and contains a gene from Bacillus thuringiensis (variety tenebrionis) (B.t.t.). for the production of the Cry3A protein. Potatoes expressing this gene are completely protected from the Colorado potato beetle (CPB) and need no additional chemical protection for this insect pest. The U.S. Food and Drug Administration (FDA), U.S. Dept. of Agriculture (USDA), and U.S. Environmental Protection Agency (EPA) have all determined that these potatoes are the same in safety and nutritional composition as any other `Russet Burbank' and `Atlantic' potatoes. These potatoes have also been approved by Health Canada, Agri-Food Canada and Agriculture Canada and by Japan and Mexico for food use. Commercial growers across North America have experienced outstanding performance while growing NewLeaf® potatoes 3 years in a row. This level of performance is the result of stable, nonsignificant differences in expression of the Cry3A gene. The stable performance, also, is a result of an effective insect resistance management program based on maintaining CPB refuges near NewLeaf ® fields, reducing CPB populations, and monitoring for CPB surviving exposure to NewLeaf® potatoes. In 1998 NewLeaf Y®), conferring resistance to both CPB and potato virus Y, and NewLeaf Plus®, conferring resistance to CPB and potato leafroll virus will be commercially released.